- AdventHealth
Nurses comprise the nation's largest group of healthcare providers, with more than 3.8 million registered nurses (RNs) nationwide and 84.5% employed in acute care nursing.
While shift work is essential to delivering acute care, numerous studies have linked it with adverse cardio-metabolic effects, including increased risk for obesity, type 2 diabetes and cardiovascular disease, as well as increased risks for mental health concerns such as depressive symptoms, anxiety and suicidal ideation.
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts:
- Well Nurse: Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses
- COMET: ImpaCt Of Shiftwork on METabolic Flexibility and Skeletal Muscle Clocks
Can exercise improve the physical and mental health impacts of nursing shift work?
Physically active people have lower cardio-metabolic risk, and exercise training can be used as therapy for mental and physical conditions. However, scant research has focused on the impact of exercise training and lifestyle behavior on RN mental health or whole person wellness. Despite well-documented health benefits of physical activity, the 2019-2020 HealthyNurse® Survey reported 19%-45% of RNs did not meet muscle strengthening, vigorous aerobic activity or light to moderate aerobic activity recommendations, respectively, and only 37% reported access to employer-based exercise facilities and programs.
Launched in spring 2023 under the leadership of AdventHealth Biobehavioral Research Scientist Andrea Brennan, PhD, in the Nursing, Whole Person and Academic Research department, the Well Nurse study is a randomized, wait-list control pilot study to analyze the impact of an on-site, 12-week exercise training intervention on post-traumatic growth and whole-person well-being (mental health, physical health, spiritual well-being, perceived social support and occupational health) among shift-working acute care nurses within AdventHealth. The study includes five phases:
- Phase I: Screening — This encompasses obtaining consent, screening for inclusion/exclusion criteria, reviewing study details, assessing the need for medical clearance to participate in the exercise intervention and a single blood draw for fasted blood profiles.
- Phase II: Baseline Assessments — Upon successful screening, all participants will complete baseline assessments of both mental and physical health outcomes. This includes blood tests, EKG, cardiometabolic risk, anthropometry, body composition test (DEXA scan), exercise capacity testing (VO2 max), wearable activity monitors and musculoskeletal strength testing as well as several questionnaires to evaluate mental and spiritual health (i.e., post-traumatic growth inventory, generalized anxiety disorder scale and job satisfaction).
- Phase III: Exercise Training — Participants will be randomized to the exercise training intervention group or the wait-list control group for a 12-week period. All exercise sessions are held at the TRI.
- Phase IV: Post-Intervention — All participants will enter a post-intervention phase that includes repeat assessments of Phase II outcomes.
- Phase V: Repeat Assessments — A subset of psychometric questionnaires will be repeated 3- and 6-months post-exercise training intervention to ascertain sustainability of the intervention.
“This study is unique in that it delivers supervised, prescriptive exercise training from credentialed professionals to shift-working nurses for 12 weeks and measures a range of wholistic health outcomes that cover the mental and physical health spectrum,” shares Dr. Brennan.
AdventHealth LPNs, RNs, and APRNs who are employed in night shift work and currently do not exercise more than one day a week are invited to participate. Night shift work is defined as working at least 8 night shifts per month for the last 12 consecutive months. A night shift is defined as at least 6 consecutive work hours between 10 pm and 8 am. Compensation is provided for completion of all study visits. In addition, those randomized to the wait-list control group are offered the opportunity to complete the exercise intervention following their 12-week control period.
Understanding the impact of shift work on healthcare employees’ metabolic function
The links between shift work and metabolic disease are not fully understood, but researchers postulate they may be related to disruption of circadian rhythms. Launched in summer 2023 and continuing through 2024, the COMET study is led by AdventHealth Translational Research Institute (TRI) Faculty Investigator Melissa Erickson, PhD, and aims to determine the impact of shift work on metabolic flexibility, which is the ability of the body to respond or adapt to changes in metabolic demand.
For the COMET study, TRI researchers will assess rates of metabolic fuel use during simulated shift work schedules via whole-room indirect calorimetry protocols that include controlled meals, sleep and exercise. They will also take blood draws frequently to assess changes in circulating hormones and sample muscle tissue during both the evening and morning to estimate skeletal muscle circadian timing.
“Using our state-of-the-art research facilities, COMET was designed to help us understand how metabolism functions during a night shift,” explains Dr. Erickson. “This new information will help us gain a better understanding of why shift work increases risk for obesity and type 2 diabetes, which is critical for developing future health and wellness programs specific to the needs of shift workers.”
Improving the lives of nurses and other healthcare workers
The AdventHealth Research Institute believes both the Well Nurse and COMET studies are critical to better understanding and addressing the needs of nurses and other healthcare employees who work night shifts.
“The physical and mental health consequences of shift work are troubling, particularly for essential workers such as nurses in which increased workloads and associated burnout exacerbate concerns for overall wellbeing,” explains Dr. Brennan. “Nurses’ health and wellbeing are integral to the provision of safe, quality patient care, positive patient-health care provider relationships, high-functioning healthcare teams, and an engaged and effective workforce. It is imperative that we identify strategies that optimize health and wellbeing to not only retain nurses, but also provide an environment in which they flourish.”
AdventHealth administration concurs on the importance of investing in these research efforts.
“Nurse well-being is a top priority for our healthcare system,” says Cathy Stankiewicz, Senior Vice President and Chief Nursing Officer for AdventHealth’s Central Florida South Region. “These studies aim to provide our healthcare professionals with comprehensive knowledge to recognize physical and mental health concerns, and the skills to practice preventive self-care.”
For more information about participating in the Well Nurse study, contact amy.west@adventhealth.com. Click here to learn more about enrollment in the COMET study.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...